Grit Biotechnology

Recent Finacing

Series B

Recent Raise

$60M

Grit Biotechnology is a Shanghai-based cell therapy company that develops transformative cancer treatments, focusing on the development of Tumor-Infiltrating Lymphocyte (TIL) products and gene-edited TIL therapies.